Trevi Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

TRVI
Trevi Therapeutics

Last Price:

$6.50

Seasonality Move:

40.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Trevi Therapeutics Stock Forecast

Over the next 52 weeks, Trevi Therapeutics has on average historically risen by 26.3% based on the past 5 years of stock performance.
Trevi Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Is Trevi Therapeutics Stock Undervalued?

The current Trevi Therapeutics [TRVI] share price is $6.50. The Score for TRVI is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
TRVI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Trevi Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Trevi Therapeutics has on average historically risen by 26.3% based on the past 5 years of stock performance.

Trevi Therapeutics Stock Rating

Buy

Trevi Therapeutics (TRVI) is a Buy

Is Trevi Therapeutics overpriced?

Trevi Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Trevi Therapeutics Stock Price History

Is TRVI stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

trevitherapeutics.com

52-Week Data

52-Week High:

7.39

52-Week Low:

2.30

Prediction Charts

Market Cap:

661.3M

Price in USD:

6.50

Volume:

1.7M

Beta:

0.57

Technical Analysis

SMA50:

6.25

SMA100:

5.19

SMA200:

4.12

52-Wk Change:

128.87%

Stock Predictions

Is Trevi Therapeutics stock public?

Yes, Trevi Therapeutics is a publicly traded company.
What is the Trevi Therapeutics stock quote today?

The Trevi Therapeutics stock price is 6.50 USD today.
How to buy Trevi Therapeutics stock online?

You can buy Trevi Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-29	6.54	6.31	6.74	6.29
Apr-30	6.25	6.91	7.02	6.14
May-1	6.87	6.90	7.16	6.73
May-2	7.00	6.99	7.24	6.78
May-5	6.98	6.90	7.16	6.69
May-6	6.80	6.58	6.85	6.56
May-7	6.59	6.66	6.78	6.50
May-8	6.67	6.60	6.78	6.37
May-9	7.13	6.60	7.17	6.37
May-12	6.61	6.70	6.83	6.55
May-13	6.74	6.46	6.83	6.40
May-14	6.49	6.19	6.78	6.19
May-15	6.21	6.19	6.33	6.12
May-16	6.19	6.50	6.70	6.19

Trevi Therapeutics Earnings

Trevi Therapeutics Earnings Report: Per Share Trevi Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Trevi Therapeutics Forecast Revenue Growth

Trevi Therapeutics Stock Analysis: Historical quarterly revenues per share for Trevi Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.07 per share.

* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.